×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Breast Cancer

Feature Video
Breast cancer is the second most commonly diagnosed cancer. Because there are many different types of breast cancer and several ways to treat the disease, CURE Connections wants to answer the questions you might have following a recent diagnosis. Throughout this program, you will hear about the different testing procedures that are available for screening, what to do once diagnosed, and how to find the best possible care team, from expert oncologists and breast cancer patients.
A comprehensive review of potential treatment options in the setting of HER2-negative breast cancer.
Experts address the questions and concerns that may follow a diagnosis of breast cancer alongside important advice and patient resources.
Key opinion leaders in the management of breast cancer outline various subtypes of this disease, as well as potential causes and risk factors.
 
Gina Columbus
The FDA has expanded the approval of Ibrance (palbociclib) capsules in combination with endocrine therapy for male patients with hormone receptor (HR)–positive, HER2-negative advanced or metastatic breast cancer.
 
Martha Carlson
Create a digital health binder, improve communication, find clinical trials and get connected with three free mobile apps.
SUSAN G. KOMEN GREATER NYC
Susan G.Komen-Greater NYC announced today the members of its newly appointed Medical Advisory Committee.
Khevin Barnes
Sometimes it takes a bigger candle to shine a light on our disease.
Jessica Skarzynski
Here are the top 5 CURE stories for March 2019.
Bonnie Annis
This week, the Food and Drug Administration (FDA) proposed changes to improve and modernize breast cancer screening. In their proposal, the FDA submitted amendments to the current regulations that would provide patients with more detailed information. This information, which would include breast density, would help patients make better decisions regarding their personal health care.
Beth Fand Incollingo
Despite emotional testimony from women who say their breast implants made them sick with cancer or autoimmune symptoms, the Food and Drug Administration (FDA) has no plans to ban the textured implants that are being blamed.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other